for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BGI Genomics Co Ltd

300676.SZ

Latest Trade

91.69CNY

Change

-1.07(-1.15%)

Volume

3,587,285

Today's Range

91.01

 - 

93.00

52 Week Range

81.01

 - 

180.00

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
92.76
Open
92.00
Volume
3,587,285
3M AVG Volume
69.21
Today's High
93.00
Today's Low
91.01
52 Week High
180.00
52 Week Low
81.01
Shares Out (MIL)
413.91
Market Cap (MIL)
37,951.80
Forward P/E
20.96
Dividend (Yield %)
0.38

Next Event

Q4 2021 BGI Genomics Co Ltd Earnings Release

Latest Developments

更多

BGI Genomics Sees 9-Month Net Profit Down 47.0-49.9% Y/Y

BGI Genomics' Chairman Plans To Increase Shareholdings In The Company

BGI Genomics' Vice General Manager Resigns Due To Personal Reasons

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BGI Genomics Co Ltd

BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as drugs basic research and clinical application services. The Company mainly provides services for domestic and overseas academic institutions, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical institutions, among others.

Industry

Biotechnology & Drugs

Contact Info

Ole Maaloees Vej 3, Copenhagen N

SHENZHEN, GNG

518083

China

+86.755.36307065

http://www.bgi.com/

Executive Leadership

Jian Wang

Chairman of the Board

Yiqing Chen

Chief Financial Officer

Zhiping Li

Chief Human Resource Officer

Ye Yin

General Manager, Director

Yutao Du

Deputy General Manager, Director

Key Stats

1.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2018

2.5K

2019

2.8K

2020

8.4K

2021(E)

6.8K
EPS (CNY)

2018

0.970

2019

0.691

2020

5.235

2021(E)

4.375
Price To Earnings (TTM)
48.44
Price To Sales (TTM)
5.58
Price To Book (MRQ)
4.10
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
13.85
LT Debt To Equity (MRQ)
8.04
Return on Investment (TTM)
8.48
Return on Equity (TTM)
6.37

Latest News

Latest News

RPT-EXCLUSIVE-Monkey-brain study with link to China's military roils top European university

A Chinese professor at the University of Copenhagen conducted genetic research with the Chinese military without disclosing the connection, the university told Reuters, in the latest example of how China's pursuit of military-civilian technology is tapping into Western academia...

EXCLUSIVE-Monkey-brain study with link to China's military roils top European university

A Chinese professor at the University of Copenhagen conducted genetic research with the Chinese military without disclosing the connection, the university told Reuters, in the latest example of how China's pursuit of military-civilian technology is tapping into Western academia...

《股市简讯》中国华大基因一度涨3.3%,拟回购至多2.6亿元股票

* 中国基因检测公司--华大基因周二早盘一度上涨3.28%,股价重回90元上方;公司昨日公告称,拟回购1.3-2.6亿元公司A股股票,用于实施员工持股计划或者股权激励。

《股市简讯》中国华大基因挫近5%创18月新低,三季度净利润料锐减逾六成

* 公司公告 http://www.szse.cn/disclosure/listed/bulletinDetail/index.html?9c244141-d5d1-4975-b0ea-51ea432d7723称,预计三季度净利为2.7-3.5亿元,同比减66.88-74.48%,因报告期内因全球新冠核酸试剂和检测单价下降,公司主动战略性调整新冠相关产品结构与供应链策略,基于新冠相关的业务收入较2020年同期较高基数相比有所下降。

EXCLUSIVE-Polish gene project moves to drop Chinese tech on data concerns

A European Union-funded project to build a genomic map of Poland plans to drop gene-sequencing technology from China's BGI Group over concerns about data security, one of the project's leaders told Reuters.

RPT-BGI prenatal gene test under scrutiny for Chinese military links

Health regulators in five countries are examining a prenatal test that collects the DNA of women and fetuses for research, while some doctors that promoted it and clinics that sell it say they were unaware the company that produces it also conducts research with the Chinese...

BGI prenatal gene test under scrutiny for Chinese military links

Health regulators in five countries are examining a prenatal test that collects the DNA of women and fetuses for research, while some doctors that promoted it and clinics that sell it say they were unaware the company that produces it also conducts research with the Chinese...

BRIEF-中国华大基因上半年净利因高基数同比减逾三成,称剔除新冠业务影响仍稳健增长

* 报告期内,公司整体营业收入较上年同期新冠疫情突发大幅增长的基数基础上略有下降,剔除新冠业务变化情况,公司常规业务板块较上年同期均实现了稳健、有机增长。

《股市简讯》中国华大基因跳水大跌逾7%,此前预计上半年净利同比降27-40%

* 中国基因检测公司--华大基因周四盘初跳水,大跌逾7%;公司昨晚发布公告称,预计上半年净利润为10-12亿元人民币,同比下降约27.34-39.45%。公司并预计,上半年营业收入约35.0-37.5亿元,同比下降约8.71-14.80%。

RPT-EXCLUSIVE-Prenatal test developed with Chinese military stores gene data

A prenatal test taken by millions of pregnant women globally was developed by Chinese gene company BGI Group in collaboration with the Chinese military and is being used by the firm to collect genetic data, a Reuters review of publicly available documents found.

EXCLUSIVE-Prenatal test developed with Chinese military stores gene data

A prenatal test taken by millions of pregnant women globally was developed by Chinese gene company BGI Group in collaboration with the Chinese military and is being used by the firm to collect genetic data, a Reuters review of publicly available documents found.

《疫情简讯》中国民航局对四家外航发出熔断指令;中国累计接种疫苗逾2.97亿剂次

* 民航局对四家外航发出熔断指令,对孟加拉优速航空公司BS325航班(达卡至广州)、卢旺达航空公司WB9500航班(基加利至广州)、伊拉克航空IA473航班(巴格达至广州)、法国航空公司AF198航班(巴黎至上海)实施熔断措施。

中国国家开发投资集团已投资华大基因

中国政府已经投资上市的中资企业华大基因(BGI Genomics Co)。该公司已经在全球范围内供应了数百万份新冠检测试剂,寻求融资支持疫情驱动的指数级增长。

Chinese state fund invests in gene firm BGI

The Chinese government has made an investment in BGI Genomics Co, a listed Chinese company that has supplied millions of COVID-19 tests globally as the gene firm seeks to fund exponential growth driven by the pandemic.

独家:中国基因组学公司华大集团与中国军方在多个领域合作

路透从研究、专利申请以及其它文件中了解到,全球最大的基因组学公司华大集团(BGI Group)一直在与中国军方合作,从事呼吸道病原体的大规模检测到脑科学等多个领域的研究。

EXCLUSIVE-China gene firm providing worldwide COVID tests worked with Chinese military

BGI Group, the world's largest genomics company, has worked with China's military on research that ranges from mass testing for respiratory pathogens to brain science, a Reuters review of research, patent filings and other documents has found.

China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia

Ethiopia has agreed to purchase 1.5 million coronavirus testing kits that will be manufactured at a factory in the African country that has been newly built by China's BGI Group, China's state media agency Xinhua said late on Tuesday.

WHO says it is in talks with China's BGI on test kit after Swedish complaint

The World Health Organization said on Thursday it was looking into whether "observed irregularities" in a COVID-19 PCR swab test made by China's BGI Biotechnology (Wuhan) Co, Ltd were linked to how it was used in Sweden.

香港特区政府称现阶段未有证据显示华大基因的检测服务质素未达标准

香港特区政府称,华大基因及其在港合资公司华昇诊断中心的检测设施均已通过卫生防护中心的新冠病毒检测外部质量评估,现阶段未有证据显示其为政府提供的检测服务质素未达标准。

China's BGI defends COVID-19 test kit after Swedish criticism

China's BGI Genomics said on Wednesday its coronavirus testing kit has "relatively high accuracy", a day after Sweden said about 3,700 people received false positive results due to a fault in the company's product.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up